The store will not work correctly when cookies are disabled.
2-benzyl-8-methoxy-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole
ID: ALA4849640
Cas Number: 69069-65-4
PubChem CID: 132599
Max Phase: Preclinical
Molecular Formula: C19H20N2O
Molecular Weight: 292.38
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: COc1ccc2[nH]c3c(c2c1)CN(Cc1ccccc1)CC3
Standard InChI: InChI=1S/C19H20N2O/c1-22-15-7-8-18-16(11-15)17-13-21(10-9-19(17)20-18)12-14-5-3-2-4-6-14/h2-8,11,20H,9-10,12-13H2,1H3
Standard InChI Key: FCUJMVMWOLCXGK-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 25 0 0 0 0 0 0 0 0999 V2000
23.0902 -17.7336 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.4245 -17.2531 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.6790 -16.4769 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.1346 -15.8704 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.3355 -16.0389 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.0837 -16.8193 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.6299 -17.4225 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.4945 -16.4764 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.7442 -17.2508 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.5353 -17.4208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.0824 -16.8193 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.8326 -16.0449 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
24.0359 -15.8720 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.3814 -15.4394 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.1802 -15.6118 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.4260 -16.3895 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.2240 -16.5622 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.7736 -15.9563 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.5198 -15.1751 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.7224 -15.0061 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7885 -15.4317 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.0409 -14.6544 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 9 1 0
8 3 1 0
2 1 1 0
2 3 2 0
3 4 1 0
4 5 2 0
5 6 1 0
6 7 2 0
7 2 1 0
8 9 2 0
8 13 1 0
9 10 1 0
10 11 1 0
11 12 1 0
12 13 1 0
12 14 1 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 15 1 0
5 21 1 0
21 22 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 292.38 | Molecular Weight (Monoisotopic): 292.1576 | AlogP: 3.73 | #Rotatable Bonds: 3 |
Polar Surface Area: 28.26 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 6.91 | CX LogP: 3.31 | CX LogD: 3.19 |
Aromatic Rings: 3 | Heavy Atoms: 22 | QED Weighted: 0.80 | Np Likeness Score: -1.00 |
References
1. Schwarthoff S, Tischer N, Sager H, Schätz B, Rohrbach MM, Raztsou I, Robaa D, Gaube F, Arndt HD, Winckler T.. (2021) Evaluation of γ-carboline-phenothiazine conjugates as simultaneous NMDA receptor blockers and cholinesterase inhibitors., 46 [PMID:34391122] [10.1016/j.bmc.2021.116355] |